Literature DB >> 16140388

Identification of immune response correlates for protection against bovine tuberculosis.

Bryce M Buddle1, D Neil Wedlock, Michel Denis, Margot A Skinner.   

Abstract

Identification of an immune response correlate for protection against bovine tuberculosis would greatly facilitate the rational development of an effective vaccine. However, finding such a correlate has been a daunting task. Vaccination/challenge studies in cattle provide an ideal platform to compare induction of immune response parameters following vaccination and challenge, and assess the correlation of these parameters with protection. Protection against tuberculosis requires a Th 1-type cell-mediated immune response and induction of an antigen-specific interferon-gamma (IFN-gamma) response was the logical first choice in an investigation to identify an immune response correlate for protection. Calf vaccination studies showed that the subcutaneous injection of BCG vaccine induced significant protection against experimental challenge with Mycobacterium bovis. This protection was associated with strong whole blood IFN-gamma responses to bovine PPD 2-4 weeks after vaccination, but within the BCG-vaccinated groups, these responses were not correlated with protection. Use of a variety of vaccination strategies has shown that IFN-gamma responses in isolation were not necessarily associated with protection and concurrent IL-4 mRNA expression or antibody responses could also be induced. Collation of an immunological profile may be more informative than a study of individual cytokines. An indication of vaccine efficacy can be provided by the study of immune responses following challenge of the calves with M. bovis. IFN-gamma responses to ESAT-6, antibody responses following tuberculin skin testing and antigen-specific IL-4 mRNA expression all correlated with the severity of disease and indirectly provided an indication of protection. Future studies should be directed towards obtaining immunological profiles of calves following vaccination using techniques such as DNA microarray analysis, measurement of cytokine mRNA expression by real-time PCR, protein profiling by SELDI-TOF mass spectrometry as well as determining cytokine production by specific T cell sub-sets in individual protected animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140388     DOI: 10.1016/j.vetimm.2005.08.002

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  26 in total

1.  Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish.

Authors:  J C Hope; M L Thom; M McAulay; E Mead; H M Vordermeier; D Clifford; R G Hewinson; B Villarreal-Ramos
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

2.  Early immune markers associated with Mycobacterium avium subsp. paratuberculosis infection in a neonatal calf model.

Authors:  J R Stabel; S Robbe-Austerman
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

3.  Immune responses and safety after dart or booster vaccination of bison with Brucella abortus strain RB51.

Authors:  S C Olsen; C Johnson
Journal:  Clin Vaccine Immunol       Date:  2012-03-29

4.  Correlation of cytokine gene expression with pathology in white-tailed deer (Odocoileus virginianus) infected with Mycobacterium bovis.

Authors:  Tyler C Thacker; Mitchell V Palmer; W Ray Waters
Journal:  Clin Vaccine Immunol       Date:  2006-06

5.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

6.  Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy.

Authors:  Doreen Manuela Floss; Michael Mockey; Galliano Zanello; Damien Brosson; Marie Diogon; Roger Frutos; Timothée Bruel; Valérie Rodrigues; Edwin Garzon; Claire Chevaleyre; Mustapha Berri; Henri Salmon; Udo Conrad; Laurence Dedieu
Journal:  J Biomed Biotechnol       Date:  2010-04-13

7.  Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone.

Authors:  D Neil Wedlock; Michel Denis; Gavin F Painter; Gary D Ainge; H Martin Vordermeier; R Glyn Hewinson; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

8.  Association of quantitative interferon-γ responses with the progression of naturally acquired Mycobacterium bovis infection in wild European badgers (Meles meles).

Authors:  Alexandra J Tomlinson; Mark A Chambers; Robbie A McDonald; Richard J Delahay
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

9.  Development and validation of an enzyme-linked immunosorbent assay for antibodies against Mycobacterium bovis in European wild boar.

Authors:  Olaia Aurtenetxe; Marta Barral; Joaquín Vicente; José de la Fuente; Christian Gortázar; Ramón A Juste
Journal:  BMC Vet Res       Date:  2008-11-01       Impact factor: 2.741

10.  Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis.

Authors:  Jean-Louis Herrmann; Marie Belloy; Raphael Porcher; Nancy Simonney; Rola Aboutaam; Muriel Lebourgeois; Joel Gaudelus; Laure De Losangeles; Katarina Chadelat; Pierre Scheinmann; Nicole Beydon; Brigitte Fauroux; Martine Bingen; Mustapha Terki; Dominique Barraud; Philippe Cruaud; Catherine Offredo; Agnes Ferroni; Patrick Berche; Didier Moissenet; Hoang Vuthien; Catherine Doit; Edouard Bingen; Philippe Henri Lagrange
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.